MGMT and astrocytoma (excluding glioblastoma): Regarding MGMT promoter methylation status, we observed that: 100% of 1p/19q codeleted gliomas, 91% of astrocytomas IDH-mutant and 50% of GBM IDH-mutant samples were methylated.